This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Aclara Biosciences Inc.
Aclara Biosciences Inc., a prominent player in the biotechnology sector, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in genomic analysis and molecular diagnostics, focusing on innovative solutions for life sciences research and clinical applications. Aclara's core offerings include advanced microfluidic technologies and high-throughput screening systems, which are designed to enhance the efficiency and accuracy of genomic studies. These unique products enable researchers to conduct complex analyses with greater precision, setting Aclara apart in a competitive market. With a strong presence in North America and expanding operations globally, Aclara Biosciences has achieved significant milestones, including collaborations with leading research institutions. The company continues to solidify its market position through cutting-edge innovations and a commitment to advancing scientific discovery.
DitchCarbon Score
How does Aclara Biosciences Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aclara Biosciences Inc.'s score of 59 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aclara Biosciences Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is part of a corporate family that includes Labcorp Holdings Inc., from which it inherits emissions data and climate commitments. As of now, Aclara has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of detailed emissions data suggests that Aclara may still be in the early stages of formalising its climate strategy. Given its relationship with Labcorp Holdings Inc., any future emissions data or climate commitments may be influenced by Labcorp's sustainability initiatives and performance metrics. As the industry increasingly prioritises carbon neutrality and sustainability, Aclara's future commitments will likely align with broader corporate trends and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 69,115,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 178,899,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aclara Biosciences Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
